On April 28-30, 2021, Childhood Cancer International – Europe (CCI Europe) will organize a conference within the Annual Meeting of the Society for Pediatric Oncology (SIOPE). CCI Europe is one of the valued Partners that participate in the HARMONY Patient Cluster.
HARMONY Key Opinion Leader for Childhood Leukemia, Prof. Anthony Moorman of Newcastle University, will present.
Professor Moorman’s presentation is scheduled on Wednesday, April 28 and specifically in the following session:
#BigDataforbloodcancer | Big Data accelerate better and faster treatment for Patients with Hematologic Malignancies
The HARMONY Alliance is a European Public–Private Partnership for Big Data in Hematology that is capturing and mining Big Data on various Hematologic Malignancies, including Pediatric Hematologic Malignancies. The HARMONY Alliance unites more than 100 organizations such as European medical associations, hospitals, research institutes, patient organizations, pharmaceutical and IT companies. HARMONY uses Big Data analytics to accelerate the development of more effective treatments for blood cancer patients. The aim is to accelerate the development of more effective treatments. Data are stored in HARMONY’s Big Data Platform, which has already identified over 60,000 anonymized patient records, making it one of the largest databases of its kind. Leading research teams are currently using this wealth of information to answer critical questions about hematologic malignancies that cannot be addressed with other methods.
HARMONY Patient Cluster
The HARMONY Patient Cluster is a unique group of seven European Patient Umbrella Organizations working in different areas of hematological diseases.
SIOP Europe Virtual Annual Meeting 2021 is a joint meeting of different European Clinical Trials Groups, Young Oncologists and Parents & Survivors representatives. The meeting format includes novel session formats, interactive workshops and forums empowering the working groups to debate and disseminate the outcomes of the high quality clinical and basic research carried out in Europe. The scientific program of the Virtual Annual Meeting will focus on joint sessions between two or more groups, enabling direct interactions between tumor and clinical trial groups, parent groups, and survivors.
See what other meetings HARMONY is holding and attending by visiting our meetings page >
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
